IDO1 and neoplasm: Many of the factors significantly associated with tumour progression and immunosuppression, such as YY1, SIRT1/3, GSK3β, STAT, IDO and the AhR can have their influence and interactions more plausibly integrated by their impacts on metabolism, acetyl-CoA and the melatonergic pathway within the cells of the tumour microenvironment.